Chemoradiation in Cervical Cancer with Cisplatin and High-Dose Rate Brachytherapy Combined with External Beam Radiotherapy

Hans‐Georg Strauß(Martin Luther University Halle-Wittenberg), G. Haensgen(Martin Luther University Halle-Wittenberg), Steffi Pigorsch(Technical University of Munich), Thomas Kuhnt(Leipzig University), Cornelia Laban(Martin Luther University Halle-Wittenberg), Heinz Koelbl(Martin Luther University Halle-Wittenberg), Juergen Dunst(Martin Luther University Halle-Wittenberg), D. Uteau Puschmann(Martin Luther University Halle-Wittenberg)
Strahlentherapie und Onkologie
July 1, 2002
10.1007/s00066-002-0956-1
Cited by 53

Related Papers

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|369
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial
|BMJ|2020|293
Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas
|International Journal of Radiation Oncology*Biology*Physics|2000|218
Anemia in cervical cancers: Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis
|International Journal of Radiation Oncology*Biology*Physics|2003|197